Douglas D. Ross
University of Maryland Greenebaum Cancer Center
University of Maryland School of Medicine
Baltimore VA Medical Center
Baltimore
USA
Name/email consistency: high
- Impact of breast cancer resistance protein on cancer treatment outcomes. Ross, D.D., Nakanishi, T. Methods Mol. Biol. (2010)
- Long-term evaluation of required coursework in palliative and end-of-life care for medical students. Ross, D.D., Shpritz, D., Hull, M.M., Goloubeva, O. J. Palliat. Med (2005)
- Mining our ABCs: pharmacogenomic approach for evaluating transporter function in cancer drug resistance. Ross, D.D., Doyle, L.A. Cancer. Cell (2004)
- Development of required postgraduate palliative care training for internal medicine residents and medical oncology fellows. Ross, D.D., Shpritz, D., Alexander, C.S., Carter, K., Edelman, M.J., Friedley, N., Hemani, A., Keay, T.J., Roy, S.C., Silverman, H., Tasker, D.J., Timmel, D., Schwartz, J., Wolfsthal, S.D. J. Cancer. Educ (2004)
- Modulation of drug resistance transporters as a strategy for treating myelodysplastic syndrome. Ross, D.D. Best. Pract. Res. Clin. Haematol (2004)
- Functional characterization of human breast cancer resistance protein (BCRP, ABCG2) expressed in the oocytes of Xenopus laevis. Nakanishi, T., Doyle, L.A., Hassel, B., Wei, Y., Bauer, K.S., Wu, S., Pumplin, D.W., Fang, H.B., Ross, D.D. Mol. Pharmacol. (2003)
- Management of common symptoms in terminally ill patients: Part I. Fatigue, anorexia, cachexia, nausea and vomiting. Ross, D.D., Alexander, C.S. Am. Fam. Physician (2001)
- Institutionalization of a palliative and end-of-life care educational program in a medical school curriculum. Ross, D.D., Fraser, H.C., Kutner, J.S. J. Palliat. Med (2001)









